Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation

Back

ESC Professional Premium Access

Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation

Session: Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations

Topic: Aortic Valve Intervention

Speaker: Doctor P. Guedeney (Paris, FR)

Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Paul Guedeney

Pitie Salpetriere APHP University Hospital, Paris (France)

0 follower

5 more presentations in this session

Trends in outcomes, complications and readmission rates in patients undergoing transcatheter aortic valve implantation: a nationwide analysis from 2012 to 2019

Speaker: Doctor A. Goel (Valhalla, US)

Hospital procedural volume and clinical outcomes for transcatheter aortic valve replacement - US nationwide readmission database, 2016-2019.

Speaker: Doctor O. Al-Taweel (Las Vegas, US)

Prevalence and prognostic impact of cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. AMY-TAVI study.

Speaker: Doctor D. Lopez Otero (Santiago de Compostela, ES)

Impact of periprocedural pulmonary hypertension on outcomes after TAVR: novel risk stratification from the OCEAN-TAVI Registry

Speaker: Doctor J. Miyamoto (Kanagawa, JP)

Bioprosthetic valve fracture during valve-in-valve transcatheter aortic valve replacement: multicenter propensity matched analysis

Speaker: Doctor G. Bonnet (Bordeaux, FR)

Access the full session

Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations

Speakers: Doctor P. Guedeney, Doctor A. Goel, Doctor O. Al-Taweel, Doctor D. Lopez Otero, Doctor J. Miyamoto...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation

About the speaker

Doctor Paul Guedeney

5 more presentations in this session

Trends in outcomes, complications and readmission rates in patients undergoing transcatheter aortic valve implantation: a nationwide analysis from 2012 to 2019

Hospital procedural volume and clinical outcomes for transcatheter aortic valve replacement - US nationwide readmission database, 2016-2019.

Prevalence and prognostic impact of cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. AMY-TAVI study.

Impact of periprocedural pulmonary hypertension on outcomes after TAVR: novel risk stratification from the OCEAN-TAVI Registry

Bioprosthetic valve fracture during valve-in-valve transcatheter aortic valve replacement: multicenter propensity matched analysis

Access the full session

Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations

About the event

ESC Congress 2022

ESC 365 is supported by